NCI Grants Establish 18 Biomarkers Developmental Laboratories

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 8 No 12
Volume 8
Issue 12

BETHESDA, Md-Nearly $8 million in grants will help 17 organizations establish 18 Biomarkers Developmental Laboratories, part of the National Cancer Institute’s new Early Detection Research Network. The laboratories are charged with identifying, characterizing, and refining techniques for finding molecular, genetic, and biologic biomarkers.

BETHESDA, Md—Nearly $8 million in grants will help 17 organizations establish 18 Biomarkers Developmental Laboratories, part of the National Cancer Institute’s new Early Detection Research Network. The laboratories are charged with identifying, characterizing, and refining techniques for finding molecular, genetic, and biologic biomarkers.

Two laboratories will be established at the University of Maryland School of Medicine. Other grants went to the University of Colorado, Yale University, Lombardi Cancer Center, the University of South Florida, Northwestern University, Johns Hopkins University, the University of Michigan, Genetica, Inc. (Cold Spring, NY), Mount Sinai School of Medicine, Duke Medical Center, Thomas Jefferson University, the University of Pittsburgh, M.D. Anderson Cancer Center, University of Texas Southwestern Medical Center (Dallas), Eastern Virginia Medical School, and the University of Washington.

Recent Videos
The addition of radioembolization to radiosensitizing chemotherapy may help concurrently treat patients with liver tumors and disease outside the liver.
In neuroendocrine tumor management, patients with insulinoma may be at risk of severe hypoglycemia following receipt of GLP-1 receptor agonists.
Decreasing the low-dose bath of proton therapy to the body may limit the impact of radiation on lymphocytes and affect tumor response.
4 experts are featured in this series.
4 experts are featured in this series.
According to Eyub Akdemir, MD, reducing EDIC may be feasible without compromising target coverage to reduce anticipated lymphopenia rates.
7 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
Related Content